Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jul;40(1):83–86. doi: 10.1111/j.1365-2125.1995.tb04540.x

Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.

E Sampol 1, B Lacarelle 1, J F Rajaonarison 1, J Catalin 1, A Durand 1
PMCID: PMC1365033  PMID: 8527274

Abstract

Zidovudine (ZDV) is extensively metabolised by the liver to an inactive glucuronide (GZDV). Since ZDV is often administered with antimycotic drugs, we studied the effect of six systemic antifungal agents on the in vitro glucuronidation of ZDV by human liver microsomes. 5-fluorocytosine and itraconazole had no inhibitory effect whereas amphotericine B, ketoconazole, miconazole and fluconazole inhibited in vitro GZDV formation (Ki values were 0.13, 0.08, 0.18 and 1.4 mM respectively).

Full text

PDF
83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back D. J., Tjia J. F. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol. 1991 Nov;32(5):624–626. doi: 10.1111/j.1365-2125.1991.tb03963.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brammer K. W., Coakley A. J., Jezequel S. G., Tarbit M. H. The disposition and metabolism of [14C]fluconazole in humans. Drug Metab Dispos. 1991 Jul-Aug;19(4):764–767. [PubMed] [Google Scholar]
  3. Burger D. M., Meenhorst P. L., Koks C. H., Beijnen J. H. Drug interactions with zidovudine. AIDS. 1993 Apr;7(4):445–460. doi: 10.1097/00002030-199304000-00001. [DOI] [PubMed] [Google Scholar]
  4. Daneshmend T. K., Warnock D. W. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet. 1983 Jan-Feb;8(1):17–42. doi: 10.2165/00003088-198308010-00002. [DOI] [PubMed] [Google Scholar]
  5. Debruyne D., Ryckelynck J. P. Clinical pharmacokinetics of fluconazole. Clin Pharmacokinet. 1993 Jan;24(1):10–27. doi: 10.2165/00003088-199324010-00002. [DOI] [PubMed] [Google Scholar]
  6. Good S. S., Reynolds D. J., de Miranda P. Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography. J Chromatogr. 1988 Sep 23;431(1):123–133. doi: 10.1016/s0378-4347(00)83075-3. [DOI] [PubMed] [Google Scholar]
  7. Heykants J., Van Peer A., Van de Velde V., Van Rooy P., Meuldermans W., Lavrijsen K., Woestenborghs R., Van Cutsem J., Cauwenbergh G. The clinical pharmacokinetics of itraconazole: an overview. Mycoses. 1989;32 (Suppl 1):67–87. doi: 10.1111/j.1439-0507.1989.tb02296.x. [DOI] [PubMed] [Google Scholar]
  8. Lavrijsen K. L., Van Houdt J. M., Van Dyck D. M., Meuldermans W. E., Heykants J. J. Induction potential of fluconazole toward drug-metabolizing enzymes in rats. Antimicrob Agents Chemother. 1990 Mar;34(3):402–408. doi: 10.1128/aac.34.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Maurice M., Pichard L., Daujat M., Fabre I., Joyeux H., Domergue J., Maurel P. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J. 1992 Jan 6;6(2):752–758. doi: 10.1096/fasebj.6.2.1371482. [DOI] [PubMed] [Google Scholar]
  10. Niemegeers C. J., Levron J. C., Awouters F., Janssen P. A. Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole. Arch Int Pharmacodyn Ther. 1981 May;251(1):26–38. [PubMed] [Google Scholar]
  11. Rajaonarison J. F., Lacarelle B., Catalin J., Placidi M., Rahmani R. 3'-azido-3'-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes. Drug Metab Dispos. 1992 Jul-Aug;20(4):578–584. [PubMed] [Google Scholar]
  12. Resetar A., Minick D., Spector T. Glucuronidation of 3'-azido-3'-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics. Biochem Pharmacol. 1991 Jul 15;42(3):559–568. doi: 10.1016/0006-2952(91)90319-z. [DOI] [PubMed] [Google Scholar]
  13. Rodrigues A. D., Gibson G. G., Ioannides C., Parke D. V. Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem Pharmacol. 1987 Dec 15;36(24):4277–4281. doi: 10.1016/0006-2952(87)90670-8. [DOI] [PubMed] [Google Scholar]
  14. Sahai J., Gallicano K., Pakuts A., Cameron D. W. Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. J Infect Dis. 1994 May;169(5):1103–1107. doi: 10.1093/infdis/169.5.1103. [DOI] [PubMed] [Google Scholar]
  15. Sim S. M., Back D. J., Breckenridge A. M. The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br J Clin Pharmacol. 1991 Jul;32(1):17–21. doi: 10.1111/j.1365-2125.1991.tb05607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stagg M. P., Cretton E. M., Kidd L., Diasio R. B., Sommadossi J. P. Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine. Clin Pharmacol Ther. 1992 Jun;51(6):668–676. doi: 10.1038/clpt.1992.79. [DOI] [PubMed] [Google Scholar]
  17. van der Hoeven T. A., Coon M. J. Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J Biol Chem. 1974 Oct 10;249(19):6302–6310. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES